CDC Online Newsroom - CDC and FDA Joint Telebriefing on Investigation of Meningitis Outbreak

This page is a historical archive and is no longer maintained.

For current information, please visit http://www.cdc.gov/media/

Media Advisory

For Immediate Release: October 11, 2012
Contact:Division of News & Electronic Media, Office of Communication
(404) 639-3286

CDC, FDA, Massachusetts Department of Public Health Joint Telebriefing Updating Investigation of Meningitis Outbreak

What

CDC, FDA, and Massachusetts Department of Public Health will host a telephone-only media availability to provide updates about the multistate investigation of meningitis among patients who have received an epidural steroid injection (medication injected into the spine) and joint injections.

When

Thursday, October 11 at 3 p.m. ET

Who

J. Todd Weber, MD, Incident Manager of the Multistate Meningitis Outbreak and Chief of Prevention and Response Branch, Division of Healthcare Quality Promotion, CDC

Deborah M. Autor, JD, Deputy Commissioner for Global Regulatory Operations and Policy, FDA

Madeleine Biondolillo, MD, Director, Department of Public Health’s Bureau of Health Care Safety and Quality, Massachusetts Department of Public Health

Dial-In

* Please dial in 10 to 15 minutes before the start of the press conference.

DIAL-IN:
Media: 888-795-0855
Non-Media: 888-942-8512
INTERNATIONAL: 415-228-3900          
PASSCODE: Meningitis

Important Instructions
If you would like to ask a question during the call, press *1 on your touchtone phone. Press *2 to withdraw your question. You may queue up at any time. You will hear a tone to indicate your question is pending.

Transcript

A transcript of this press conference will be available following the briefing at www.cdc.gov/media.

###
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO